Advertisement

Topics

Cell Medica buys clinical-phase cell therapy from Catapult

05:54 EDT 21 Jun 2017 | SmartBrief

Catapult Therapy TCR and its Phase I/II Wilms' tumor 1 protein-T-cell receptor T-cell therapy candidate will be purchased by  -More

Original Article: Cell Medica buys clinical-phase cell therapy from Catapult

NEXT ARTICLE

More From BioPortfolio on "Cell Medica buys clinical-phase cell therapy from Catapult"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...